# Microbial Phagocytic Receptors and Their Potential Involvement in Cytokine Induction in Macrophages

**Authors:** Yan Lin Fu, Rene E. Harrison

PMC · DOI: 10.3389/fimmu.2021.662063 · Frontiers in Immunology · 2021-04-29

## TL;DR

This review explores how macrophage phagocytic receptors interact with microbes and influence cytokine production, linking phagocytosis to inflammation.

## Contribution

The paper highlights the gap in direct evidence connecting phagocytosis of microbial particles to macrophage cytokine production.

## Key findings

- Macrophages secrete both pro-inflammatory and anti-inflammatory cytokines in response to immune signals.
- NF-κB signaling is a key regulator of inflammatory responses triggered by microbial ligands.
- Current knowledge on cytokine production is mostly based on soluble ligands, not particulate microbes.

## Abstract

Phagocytosis is an essential process for the uptake of large (>0.5 µm) particulate matter including microbes and dying cells. Specialized cells in the body perform phagocytosis which is enabled by cell surface receptors that recognize and bind target cells. Professional phagocytes play a prominent role in innate immunity and include macrophages, neutrophils and dendritic cells. These cells display a repertoire of phagocytic receptors that engage the target cells directly, or indirectly via opsonins, to mediate binding and internalization of the target into a phagosome. Phagosome maturation then proceeds to cause destruction and recycling of the phagosome contents. Key subsequent events include antigen presentation and cytokine production to alert and recruit cells involved in the adaptive immune response. Bridging the innate and adaptive immunity, macrophages secrete a broad selection of inflammatory mediators to orchestrate the type and magnitude of an inflammatory response. This review will focus on cytokines produced by NF-κB signaling which is activated by extracellular ligands and serves a master regulator of the inflammatory response to microbes. Macrophages secrete pro-inflammatory cytokines including TNFα, IL1β, IL6, IL8 and IL12 which together increases vascular permeability and promotes recruitment of other immune cells. The major anti-inflammatory cytokines produced by macrophages include IL10 and TGFβ which act to suppress inflammatory gene expression in macrophages and other immune cells. Typically, macrophage cytokines are synthesized, trafficked intracellularly and released in response to activation of pattern recognition receptors (PRRs) or inflammasomes. Direct evidence linking the event of phagocytosis to cytokine production in macrophages is lacking. This review will focus on cytokine output after engagement of macrophage phagocytic receptors by particulate microbial targets. Microbial receptors include the PRRs: Toll-like receptors (TLRs), scavenger receptors (SRs), C-type lectin and the opsonic receptors. Our current understanding of how macrophage receptor stimulation impacts cytokine production is largely based on work utilizing soluble ligands that are destined for endocytosis. We will instead focus this review on research examining receptor ligation during uptake of particulate microbes and how this complex internalization process may influence inflammatory cytokine production in macrophages.

## Linked entities

- **Proteins:** TNF (tumor necrosis factor), IL1B (interleukin 1 beta), IL6 (interleukin 6), CXCL8 (C-X-C motif chemokine ligand 8), IL12 (Interleukin 12 level), IL10 (interleukin 10), TGFB1 (transforming growth factor beta 1), NFKB1 (nuclear factor kappa B subunit 1)

## Full-text entities

- **Genes:** Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, LOC641025 (Ig heavy chain Mem5-like) [NCBI Gene 641025] {aka CRP55H, IGHV, IgVH, Igh, Igm}, Ticam2 (TIR domain containing adaptor molecule 2) [NCBI Gene 225471] {aka B430113A10, TICAM-2, TRAM, Tirp, Trif}, Ptprj (protein tyrosine phosphatase receptor type J) [NCBI Gene 19271] {aka BET, Byp, CD148, DEP-1, PTPbeta2, Ptpb2}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Ly96 (lymphocyte antigen 96) [NCBI Gene 17087] {aka ESOP-1, MD-2, MD2}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Syk (spleen tyrosine kinase) [NCBI Gene 20963] {aka Sykb}, Mcpt1 (mast cell protease 1) [NCBI Gene 17224] {aka Mcp-1}, IL12B (interleukin 12B) [NCBI Gene 3593] {aka CLMF, CLMF2, IL-12B, IMD28, IMD29, NKSF}, Rac1 (Rac family small GTPase 1) [NCBI Gene 19353] {aka D5Ertd559e}, Clec7a (C-type lectin domain family 7, member a) [NCBI Gene 56644] {aka BGR, Clecsf12, beta-GR}, CLEC4E (C-type lectin domain family 4 member E) [NCBI Gene 26253] {aka CLECSF9, MINCLE}, TREM1 (triggering receptor expressed on myeloid cells 1) [NCBI Gene 54210] {aka CD354, TREM-1}, CD14 (CD14 molecule) [NCBI Gene 929], Marco (macrophage receptor with collagenous structure) [NCBI Gene 17167] {aka Ly112, Scara2}, Tlr12 (toll-like receptor 12) [NCBI Gene 384059] {aka Gm1365, Tlr11}, TLR5 (toll like receptor 5) [NCBI Gene 7100] {aka MELIOS, SLE1, SLEB1, TIL3}, MSR1 (macrophage scavenger receptor 1) [NCBI Gene 4481] {aka CD204, SCARA1, SR-A, SR-AI, SR-AII, SR-AIII}, CLEC7A (C-type lectin domain containing 7A) [NCBI Gene 64581] {aka BGR, CANDF4, CD369, CLECSF12, DECTIN1, SCARE2}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, ERVK-3 (endogenous retrovirus group K member 3) [NCBI Gene 100862689] {aka c3_B}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, CLEC6A (C-type lectin domain containing 6A) [NCBI Gene 93978] {aka CLEC4N, CLECSF10, dectin-2, hDECTIN-2}, Trem1 (triggering receptor expressed on myeloid cells 1) [NCBI Gene 58217], Il4 (interleukin 4) [NCBI Gene 16189] {aka BSF-1, Il-4}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, Trem2 (triggering receptor expressed on myeloid cells 2) [NCBI Gene 83433] {aka TREM-2, Trem2a, Trem2b, Trem2c}, Nectin1 (nectin cell adhesion molecule 1) [NCBI Gene 58235] {aka Cd111, HIgR, HveC, PRR, PRR1, Pvrl1}, Nr3c2 (nuclear receptor subfamily 3, group C, member 2) [NCBI Gene 110784] {aka MR, Mlr}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, Mmp9 (matrix metallopeptidase 9) [NCBI Gene 17395] {aka B/MMP9, Clg4b, Gel B, MMP-9, pro-MMP-9}, TLR2 (toll like receptor 2) [NCBI Gene 7097] {aka CD282, TIL4}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Clec4d (C-type lectin domain family 4, member d) [NCBI Gene 17474] {aka Clecsf8, Mpcl, mcl}, Rhoa (ras homolog family member A) [NCBI Gene 11848] {aka Arha, Arha1, Arha2}, PRRT2 (proline rich transmembrane protein 2) [NCBI Gene 112476] {aka BFIC2, BFIS2, DSPB3, DYT10, EKD1, FICCA}, Itgam (integrin alpha M) [NCBI Gene 16409] {aka CD11b/CD18, CR3, CR3A, Cd11b, F730045J24Rik, Ly-40}, Msr1 (macrophage scavenger receptor 1) [NCBI Gene 20288] {aka MRS-A, MSR, MSR-A, SR-A, SR-AI, SR-AII}, CD209 (CD209 molecule) [NCBI Gene 30835] {aka CDSIGN, CLEC4L, DC-SIGN, DC-SIGN1, hDC-SIGN}, Ikbkb (inhibitor of kappaB kinase beta) [NCBI Gene 16150] {aka IKK-2, IKK-B, IKK-beta, IKK2, IKK[b], IKKbeta}, Clec10a (C-type lectin domain family 10, member A) [NCBI Gene 17312] {aka CD301a, M-ASGP-BP-1, Mgl, Mgl1}, SYK (spleen associated tyrosine kinase) [NCBI Gene 6850] {aka IMD82, p72-Syk}, Nfkbia (nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha) [NCBI Gene 18035] {aka Nfkbi}, TREM2 (triggering receptor expressed on myeloid cells 2) [NCBI Gene 54209] {aka AD17, PLOSL2, TREM-2, Trem2a, Trem2b, Trem2c}, PRKCE (protein kinase C epsilon) [NCBI Gene 5581] {aka PKCE, nPKC-epsilon}, Ptprc (protein tyrosine phosphatase receptor type C) [NCBI Gene 19264] {aka B220, CD45R, Cd45, L-CA, Ly-5, Lyt-4}, Cd14 (CD14 antigen) [NCBI Gene 12475], TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, Src (src proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 20779] {aka pp60c-src}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, Dcn (decorin) [NCBI Gene 13179] {aka DC, DSPG2, PG40, PGII, PGS2, SLRR1B}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, CLEC4D (C-type lectin domain family 4 member D) [NCBI Gene 338339] {aka CD368, CLEC-6, CLEC6, CLECSF8, Dectin-3, MCL}, Tlr2 (toll-like receptor 2) [NCBI Gene 24088] {aka Ly105}, Csf2 (colony stimulating factor 2 (granulocyte-macrophage)) [NCBI Gene 12981] {aka CSF, Csfgm, GMCSF, Gm-CSf, MGI-IGM}
- **Diseases:** fungal (MESH:D009181), infection (MESH:D007239), N. meningitides (MESH:D008581), inflammatory (MESH:D007249), septic shock (MESH:D012772), nontypeable Haemophilus influenzae (MESH:D006192), malaria (MESH:D008288), tumor (MESH:D009369), pneumonia (MESH:D011014), necrotic (MESH:D009336)
- **Chemicals:** LPS (MESH:D008070), calcium (MESH:D002118), mannose (MESH:D008358), diacylglycerol (MESH:D004075), lipid (MESH:D008055), lipopeptides (MESH:D055666), lipoarabinomannan (MESH:C050016), latex (MESH:D007840), ROS (MESH:D017382), cyto D (MESH:D015638), glycosphingolipids (MESH:D006028), thioglycollate (MESH:D013864), zymosan (MESH:D015054), glycolipid (MESH:D006017), TDM (MESH:D003311), beta-glucan (MESH:D047071), LTA (MESH:C009900), arachidonic acid (MESH:D016718), Calmette-Guerin (-), carbohydrate (MESH:D002241), superoxide (MESH:D013481), H2O2 (MESH:D006861),  (MESH:D016207),  (MESH:D000942)
- **Species:** Staphylococcus aureus (species) [taxon 1280], Mycobacteroides abscessus (species) [taxon 36809], Haemophilus influenzae (species) [taxon 727], Candida albicans (species) [taxon 5476], Pneumocystis carinii (species) [taxon 4754], Aspergillus fumigatus (species) [taxon 746128], Acinetobacter baumannii (species) [taxon 470], Listeria monocytogenes (species) [taxon 1639], Escherichia coli (E. coli, species) [taxon 562], Streptococcus pneumoniae (species) [taxon 1313], Nakaseomyces glabratus (species) [taxon 5478], Pseudomonas aeruginosa (species) [taxon 287], Tannerella forsythia (species) [taxon 28112], Fusobacterium nucleatum (species) [taxon 851], Leishmania donovani (species) [taxon 5661], Mus musculus (house mouse, species) [taxon 10090], Plasmodium falciparum (malaria parasite P. falciparum, species) [taxon 5833], Rattus norvegicus (brown rat, species) [taxon 10116], Klebsiella pneumoniae (species) [taxon 573], Exserohilum rostratum (species) [taxon 1659837], Trypanosoma cruzi (species) [taxon 5693], Staphylococcus epidermidis (species) [taxon 1282], Aggregatibacter actinomycetemcomitans (species) [taxon 714], Histoplasma capsulatum (species) [taxon 5037], Aspergillus fumigatus var. fumigatus (varietas) [taxon 41122], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Homo sapiens (human, species) [taxon 9606], Cryptococcus neoformans (Cryptococcus neoformans serotype A, species) [taxon 5207], Mycobacterium tuberculosis (species) [taxon 1773], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Malassezia (genus) [taxon 55193]
- **Cell lines:** HEK293 cellsRAW264.7 — Homo sapiens (Human), Transformed cell line (CVCL_E149), THP1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006), SR — Mus musculus (Mouse), Malignant neoplasms of the mouse mammary gland, Cancer cell line (CVCL_S164), RAW264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC8117099/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC8117099/full.md

## References

139 references — full list in the complete paper: https://tomesphere.com/paper/PMC8117099/full.md

---
Source: https://tomesphere.com/paper/PMC8117099